Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLUPENTIXOL\MELITRACEN: 66 Adverse Event Reports & Safety Profile

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain
66
Total FAERS Reports
2 (3.0%)
Deaths Reported
41
Hospitalizations
66
As Primary/Secondary Suspect
5
Life-Threatening

Active Ingredient: FLUPENTIXOL DIHYDROCHLORIDE\MELITRACEN HYDROCHLORIDE ·

First Report: 20060118 · Latest Report: 20250313

What Are the Most Common FLUPENTIXOL\MELITRACEN Side Effects?

#1 Most Reported
Tremor
10 reports (15.2%)
#2 Most Reported
Hallucination
9 reports (13.6%)
#3 Most Reported
Drug ineffective
9 reports (13.6%)

All FLUPENTIXOL\MELITRACEN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Tremor 10 15.2% 0 4
Drug ineffective 9 13.6% 0 6
Hallucination 9 13.6% 0 4
Anxiety 7 10.6% 0 4
Constipation 7 10.6% 0 1
Dysphagia 7 10.6% 0 1
Muscular weakness 7 10.6% 0 2
Basal cell carcinoma 6 9.1% 0 3
Fatigue 6 9.1% 0 1
Gait disturbance 6 9.1% 0 1
Oedema 6 9.1% 0 6
Serotonin syndrome 6 9.1% 0 6
Anger 5 7.6% 0 0
Communication disorder 5 7.6% 0 0
Confusional state 5 7.6% 0 0
Depressed level of consciousness 5 7.6% 0 0
Dizziness 5 7.6% 0 3
Drug interaction 5 7.6% 0 4
Dysstasia 5 7.6% 0 0
Facial paralysis 5 7.6% 0 0

Who Reports FLUPENTIXOL\MELITRACEN Side Effects? Age & Gender Data

Gender: 83.6% female, 16.4% male. Average age: 61.4 years. Most reports from: CN. View detailed demographics →

Is FLUPENTIXOL\MELITRACEN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2006 1 1 0
2013 2 0 2
2014 3 0 3
2015 3 0 2
2016 3 0 3
2017 1 0 1
2018 5 1 4
2019 8 0 1
2020 1 0 1
2021 1 0 0
2022 3 0 2
2023 2 0 2
2024 4 0 3
2025 1 0 1

View full timeline →

What Is FLUPENTIXOL\MELITRACEN Used For?

IndicationReports
Product used for unknown indication 25
Anxiety 7
Depression 7

Official FDA Label for FLUPENTIXOL\MELITRACEN

Official prescribing information from the FDA-approved drug label.